Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of product candidates and diagnostic assays for patients suffering from Alzheimer’s disease and other neurodegenerative disorders, announced that it will be presenting two scientific posters at the 14th Annual Clinical Trials on Alzheimer’s Disease conference to be held on November 9-12, 2021 in Boston, MA, USA.
November 1, 2021
· 11 min read